Breaking News
Upgrade 0
💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains instead Unlock them all
Close

CompuGroup Medical AG O.N. (COP1n)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14.32 +0.05    +0.35%
06/09 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  DE000A288904 
S/N:  A28890
  • Volume: 1
  • Bid/Ask: 14.10 / 14.14
  • Day's Range: 14.32 - 14.32
CompuGroup AG 14.32 +0.05 +0.35%

Compugroup Medical AG Company Profile

 
Get an in-depth profile of CompuGroup Medical AG O.N., including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustrySoftware & IT Services
SectorTechnology
Employees

8424

Equity Type

ORD

CompuGroup Medical SE & Co. KGaA provides e-health services worldwide. It operates through Ambulatory Information Systems, Hospital Information Systems, Consumer and Health Management Information Systems, and Pharmacy Information Systems segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks; offers supplementary app, internet, and intranet solutions; and delivers solutions for medical facilities, such as medica; care centers and practice associations. The Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; provides software solutions for administration, planning and provision of care in outpatient and inpatient medical facilities; and healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer and Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, patient portals, and mobile apps; and operates telematics infrastructure business, that offers secure links, as well as security solutions for service providers. The Pharmacy Information Systems segment develop and sell administrative and billing related software applications, including procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. The company was founded in 1987 and is headquartered in Koblenz, Germany.

Contact Information

Address Maria Trost 21
Koblenz, 56070
Germany
Phone 49 261 8000 0
Fax 49 261 8000 1166

Top Executives

Name Age Since Title
Volker Kohl 50 2020 Employee Representative Member of Supervisory Board a
Claudia Frevel 56 2020 Employee Representative Member of Supervisory Board
Ursula Keller - 2020 Employee Representative Member of Supervisory Board
Philipp von Ilberg 58 2020 Chairman of Supervisory Board
Matthias Stormer 56 2020 Member of Supervisory Board
Stefan Weinmann 43 2021 Vice Chairman of the Supervisory Board
Adelheid Hegemann - 2021 Employee Representative Member of Supervisory Board
Frank Betz 56 2021 Employee Representative Member of Supervisory Board
Ayfer Basal - 2021 Employee Representative Member of Supervisory Board
Dierk Heimann - - Member of Medical Advisory Board
Bettina Volkens 60 2020 Member of Supervisory Board
Ulrike Handel 52 2020 Independent Member of Supervisory Board
Martin Kohrmann 52 2020 Member of Supervisory Board
Reinhard Lyhs 74 2023 Member of Supervisory Board
Julia Mole 36 2021 Employee Representative Member of Supervisory Board
Ali Yener 53 2024 Employee Representative Member of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

COP1n Comments

Write your thoughts about Compugroup Medical AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ιωάννης Καραγιαννάκης
Ιωάννης Καραγιαννάκης Jul 10, 2024 6:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Does anyone knows what happened with this stock in the last two days and plummeted?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email